Ophthalmology

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The health insurance provider said it believes up to 20% of all cataract surgeries may be unnecessary, but ophthalmology groups disagree.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the process of cataract development and its prevalence in both older and younger populations.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The manipulation of key enzymes through methods of gene therapy was shown to provide protection against vision loss from multiple retinal conditions.

Bobeck Modjtahedi, MD, highlights some of the challenges of using telehealth to treat individuals with diabetic retinopathy.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.

Hormonal contraceptive use among women of childbearing age was associated with a more than 2-fold higher risk of developing glaucoma, although risk was still relatively low.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

A new meta-analysis finds rigorous evidence lacking; however, existing data suggest preservative-free formulations of beta-blockers may work just as well as preserved beta-blockers in reducing intraocular pressure.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Over 20 years, 1 in 4 patients with ocular hypertension suffered visual field loss from primary open-angle glaucoma, according to a new study.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Classification criteria developed using machine learning will allow doctors to conduct disease-specific research about this collection of inflammatory eye diseases.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Patients with glaucoma who were tested under a quantum dot LED were able to better distinguish differences in color, indicating that the quality of light systems may have an impact on color discrimination.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

A reported association between sex and mild ABCA4 alleles among patients with Stargardt disease did not hold up upon reevaluation.

Optogenics was used to partially restore a blind man’s eyesight; the FDA could soon approve Moderna’s COVID-19 vaccine for use among adolescents; HHS calls for a new investigation into COVID-19’s origins.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The technique uses optical coherence tomography angiography to assess the motion of blood flow, instead of static images.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO).